Literature DB >> 28749526

Adaptation to the Spanish population of the Substance Use Risk Profile Scale (SURPS) and psychometric properties.

Fermín Fernández-Calderón1, Carmen Díaz-Batanero, Antonio J Rojas-Tejada, Natalie Castellanos-Ryan, Óscar M Lozano-Rojas.   

Abstract

The identification of different personality risk profiles for substance misuse is useful in preventing substance-related problems. This study aims to test the psychometric properties of a new version of the Substance Use Risk Profile Scale (SURPS) for Spanish college students. Cross-sectional study with 455 undergraduate students from four Spanish universities. A new version of the SURPS, adapted to the Spanish population, was administered with the Beck Hopelessness Scale, the UPPS-P Impulsive Behavior Scale, the State-Trait Anxiety Inventory (STAI) and the Alcohol Use Disorders Identification Test (AUDIT). Internal consistency reliability ranged between 0.652 and 0.806 for the four SURPS subscales, while reliability estimated by split-half coefficients varied from 0.686 to 0.829. The estimated test-retest reliability ranged between 0.733 and 0.868. The expected four-factor structure of the original scale was replicated. As evidence of convergent validity, we found that the SURPS subscales were significantly associated with other conceptually-relevant personality scales and significantly associated with alcohol use measures in theoretically-expected ways. This SURPS version may be a useful instrument for measuring personality traits related to vulnerability to substance use and misuse when targeting personality with preventive interventions.

Entities:  

Mesh:

Year:  2018        PMID: 28749526     DOI: 10.20882/adicciones.909

Source DB:  PubMed          Journal:  Adicciones        ISSN: 0214-4840            Impact factor:   2.979


  1 in total

1.  Concordance between the original and short version of the Impulsive Behaviour Scale UPPS-P using an IRT model.

Authors:  Óscar M Lozano; Carmen Díaz-Batanero; Antonio J Rojas; Angelina Pilatti; Fermín Fernández-Calderón
Journal:  PLoS One       Date:  2018-03-21       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.